Prophylactic therapy for haemophilia: Early experience

Haemophilia

Volumn 9, Issue SUPPL. 1, 2003, Pages 5-9

  Berntorp, Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arthropathy; Factor IX; Factor VIII; Haemophilia; Joint haemorrhage; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ADOLESCENT; ADULT; AGE; ARTHROPATHY; ARTICLE; BLEEDING TENDENCY; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; FREQUENCY ANALYSIS; HEALTH ECONOMICS; HEMARTHROSIS; HEMOPHILIA; HISTORY OF MEDICINE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBSTITUTION THERAPY;

EID: 0038779251     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.9.s1.3.x     Document Type: Article

References (25)

1. Ramgren O. Hemophilia in Sweden. III. Symptomatology with special reference to differences between hemophilia A and B. Acta Med Scand 1962; 171: 237-42.
2. Ahlberg Å. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; 77 (Suppl.): 1-98.
3. Soreff J, Blombäck M. Arthropathy in children with severe hemophilia A. Acta Paediatr Scand 1980; 69: 667-73.
4. Berntorp E. Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment. Haemophilia 1995; 1 (Suppl. 1): 3-7.
5. Nilsson IM. Replacement therapy. In: Haemophilia. Stockholm: Pharmacia Plasma Products, 1994; 30-49.
6. Manco-Johnson MJ, Nuss R, Geraghty S et al. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol 1994; 47: 113-7.
7. Ljung R. Second Workshop of the European Paediatric Network for Haemophilia Management, 17-19 September 1998 in Vitznau/Switzerland. Haemophilia 1999; 5 (4): 286-91.
8. Nilsson IM, Blombäck M, Ahlberg Å. Our experience in Sweden with prophylaxis on haemophilia. Proceedings of the 5th Congress of the World Federation of Hemophilia, Montreal 1968; Bibl Haematol, No. 34. New York: Karger, 1970; 111-24.
9. Nilsson IM, Hedner U, Ahlberg Å. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand 1976; 65: 129-35.
10. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe hemophilia A and B. J Int Med 1992; 232: 25-32.
11. Ljung R, Petrini P, Lindgren A-K, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Paediatr 1992; 82: 918-20.
12. Pettersson H, Ahlberg Å, Nilsson IM. A radiological classification of hemophilic arthropathy. Clin Orthop 1980; 149: 153-9.
13. Pettersson H, Gilbert M. Diagnostic Imaging in Hemophilia: Musculoskeletal and Other Hemorrhagic Complications. Berlin: Springer-Verlag, 1985; 56-65.
14. Petrini P, Lindvall N, Egberg N, Blombäck M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediat Hemat/Oncol 1991; 13: 280-7.
15. Johnson JB. The management of hemophilia with lyophile human plasma intravenously injected. J Am Med Assoc 1942; 118: 799-802.
16. Kasper CK, Dietrich SL, Rapaport SI. Hemophilia prophylaxis with factor VIII concentrate. Arch Intern Med 1970; 125: 1004-9.
17. van Creveld S. Prophylaxis of joint haemorrhages in haemophilia. Acta Haematol 1971; 45: 120-7.
18. Aronstam A, Arblaster PG, Rainsford SG et al. Prophylaxis in haemophilia: a double-blind controlled trial. Br J Haematol 1976; 33: 81-90.
19. Schimpf K, Fischer B, Rothmann P. Die ambulante Dauerbehandlung der Hämophilie A. Dtsch Med Wochenschr 1976; 101: 141-8.
20. Morfini A, Mannucci PM, Mariani G et al. Evolution of prophylactic replacement therapy in haemophilia B. Scand J Haematol 1976; 16: 41-7.
21. Schramm W. Experience with prophylaxis in Germany. Semin Hematol 1993; 30: 12-5.
22. van den Berg HM, Nieuwenhuis HK, Mauser-Bunschoten EP, Roosendaal G. Hemophilia prophylaxis in the Netherlands. Semin Haematol 1994; 31: 13-5.
23. Aledort LM, Haschemeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Int Med 1994; 236: 391-9.
24. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92: 973-8.
25. Löfqvist T, Nilsson IM, Berntorp, E, Pettersson H. Haemophilia prophylaxis in young patients: a longterm follow-up. J Int Med 1997; 241: 395-400.